WO2024241248 - COMPOUNDS TARGETING KRAS G12D MUTATIONS AND THEIR USES
National phase entry is expected:
Publication Number
WO/2024/241248
Publication Date
28.11.2024
International Application No.
PCT/IB2024/054989
International Filing Date
22.05.2024
Title **
[English]
COMPOUNDS TARGETING KRAS G12D MUTATIONS AND THEIR USES
[French]
COMPOSÉS CIBLANT DES MUTATIONS DE KRAS G12D ET LEURS UTILISATIONS
Applicants **
INNOPHARMASCREEN INC.
Inventors
KANG, Incheol
SEO, Seungoh
Priority Data
10-2023-0065774
22.05.2023
KR
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 2333 | |
| EPO | Filing, Examination, Granting | 12814 | |
| Japan | Filing, Examination, Granting | 2061 | |
| South Korea | Filing, Examination, Granting | 1553 | |
| USA | Filing, Examination, Granting | 7140 |
Total:
25,901
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Contact Us
Abstract[English]
The present disclosure relates to compounds targeting KRAS G12D and G12V mutations and uses thereof.[French]
La présente invention concerne des composés ciblant des mutations de KRAS G12D et G12V et leurs utilisations.